As a full service Contract Research Organization, it is important to ensure constant exposure in the industry for Veristat.  This is why Veristat is proud to announce its advertisement in the August issue of the DIA Global Forum. With a successful DIA meeting behind us we begin to look forward to the rest of 2010 to see how we can assist companies in efficiently conducting clinical trials.

Veristat is happy to be an active participant in DIA and is looking forward to the new advertising opportunity.  Please look for our ad next month.

Veristat would love the opportunity to hear from you.  Please contact Cindy Henderson at info@veristat.com

Veristat knows that in order to succeed as a full service contract research organization it is vital to distinguish itself in this industry.  Many sources have looked to contract research organizations to continue growing and according to the article, Playing Big Pharma with CRO’s, this trend will continue.  As a mid-sized, full service CRO Veristat is able to closely monitor costs and maximize efficiencies for pharmaceutical, biotech and medical device companies.  As this article shows, outsourcing to a CRO will provide greater efficiencies to a company’s bottom line and to their drug development programs.

Our size, in comparison to larger competitors, allows Veristat to be an extension of your organization and a partner to your team. This is especially beneficial in allowing your company to specialize in the areas of drug development expertise while Veristat assists you in running your clinical programs.   All the while we create maximum efficiencies, provide you with excellence from our teams, and monitor costs to help keep your clinical study in budget.

Our clinical trial partnerships begin with strategic consulting and medical writing of your protocols and continue on to encompass clinical monitoring, data management, biostatistical analysis, programming, FDA representation, and CDISC Implementation.

For more information on Veristat please contact Cindy Henderson at info@veristat.com

Thank You from Your CRO

As another year has halfway come and gone Veristat, your full service Contract Research Organization, would like to say thank you to all of our clients and vendors.  It has been another wonderful year and we are happy to provide our customized service and partnership approach to each project we work on with you.

Veristat works with our clients to provide the best of our service offerings in areas of clinical monitoring, data management, biostatistics, medical writing, CDISC, strategic consulting, FDA representation, safety, and for DSMB support.  We pride ourselves on becoming an extension of your company and having the flexibility to do so.

Should you wish to know more about our service offerings please contact Cindy Henderson at cindy.henderson@veristat.com

Veristat at DIA

The 46^th Annual DIA went off without a hitch as Veristat, a full service Contract Research Organization, exhibited at Booth 930.  With the Washington Convention Center full and buzzing it was a great opportunity to meet and talk with our current clients and those who we look forward to working with on their clinical trials in the future. As a full service Contract Research Organization we are able to offer a great variety and of course a great team to Sponsor’s.

This week Veristat did the drawing for the apple iPAD.  We are pleased to congratulate the winner: Shawna Ruffin with CSL Behring.  Shawna thank you for stopping by our booth and helping make this a great DIA for Veristat.

For more information on how Veristat can assist you with your clinical trial needs please contact Cindy Henderson at info@veristat.com

As a full service Contract Research Organization, Veristat’s commitment to integrity and high quality create many opportunities for company growth and repeat business.  One key element in our quality management approach is our Corrective Action/Preventive Action (CAPA) Reporting system, which was implemented in August 2009.  With an emphasis on compliance, CAPAs are required for all deviations, whether intentional (e.g., a deviation from standard procedures directed by a client) or unintentional, as a result of human error.  We also capture client satisfaction data as well as recommendations for process improvements.  For example, some process improvements are modifications to current systems or SOPs, or implementation of new processes, or enhanced training.  CAPA reports may be submitted by any employee, and the system’s tracker and all CAPA reports are transparent and visible to all employees 24/7.  As illustrated in this white page, CAPA is especially important in the healthcare industry.  As a top-notch, competitive CRO, Veristat is keeping up with industry standards. http://www.metricstream.com/whitepapers/html/corrective_preventive_actions.htm

In our first year, we have learned that communication and resolution are the most important elements of the system.  The reporting process has been augmented to ensure that all involved team members, all relevant line managers, and key senior managers are notified about the CAPA prior to its formal submission.  In our experience, this notification step helps to build consensus and clarity regarding the root cause at issue.  This helps pave the way for agreement on the action items recommended for resolution.  Resolution is pivotal to successful implementation of process improvements.

The stated goal of Veristat’s CAPA system is to improve Veristat, a full service CRO, as a company.  We always are striving to better ourselves and our CAPA system is proof of that commitment.  For more information on how Veristat can assist your clinical trial needs please contact Nicole Powell at info@veristat.com